Tod Northman provided “Monthly Deep Focus” commentary to Rx Data News in its issue dedicated to artificial intelligence (AI). Commenting on the impact that AI will have on clinical trials, Tod said, “The increasing complexity of clinical drug trials in the United States has resulted in the cost and time to commercialize a drug to skyrocket. In this context, artificial intelligence appears perfectly timed to help reduce the costs and time for clinical trials while potentially providing better results.”

Read more of Tod’s commentary here.